- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/55 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
Patent holdings for IPC class A61K 47/55
Total number of patents in this class: 1945
10-year publication summary
|
73
|
125
|
142
|
151
|
170
|
248
|
241
|
272
|
237
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Purdue Research Foundation | 3753 |
54 |
| Dana-Farber Cancer Institute, Inc. | 2621 |
46 |
| Yale University | 2453 |
37 |
| The Regents of the University of California | 20315 |
33 |
| Sapreme Technologies B.V. | 90 |
33 |
| Arvinas Operations, Inc. | 242 |
27 |
| Kymera Therapeutics, Inc. | 244 |
22 |
| Uppthera Inc. | 20 |
17 |
| University of Southern California | 2125 |
15 |
| Zevra Therapeutics, Inc. | 105 |
15 |
| Wisconsin Alumni Research Foundation | 3901 |
13 |
| Elysium Therapeutics, Inc. | 20 |
12 |
| Endocyte, Inc. | 111 |
12 |
| Extend Biosciences, Inc. | 24 |
12 |
| Glaxosmithkline Intellectual Property Development Limited | 777 |
11 |
| The Board of Trustees of the Leland Stanford Junior University | 6552 |
11 |
| The Brigham and Women's Hospital, Inc. | 2232 |
11 |
| Bicyclerd Limited | 147 |
11 |
| Charite - Universitatsmedizin Berlin | 383 |
10 |
| Icahn School of Medicine at Mount Sinai | 979 |
10 |
| Other owners | 1533 |